METMetLife exhibits a solid fundamental profile with stable profitability and a healthy balance sheet, supported by a consistent dividend. Thematic tailwinds in insurance and retirement solutions are present, but current technical indicators suggest a neutral to slightly cautious short-term outlook.
MetLife is well-positioned in essential financial services like insurance and retirement solutions, benefiting from demographic trends and increasing demand for financial security.
MetLife demonstrates strong profitability, a robust balance sheet, and consistent cash flow generation. Its valuation metrics are reasonable, and the dividend yield is attractive.
MetLife's stock is trading below key moving averages, indicating a bearish short-term trend. Oscillators suggest oversold conditions, which could signal a potential rebound, but confirmation is needed.
| Factor | Score |
|---|---|
| Demographic Trends (Aging Population) | 85 |
| Market for Retirement Solutions | 80 |
| Digital Transformation in Insurance | 65 |
| Economic Sensitivity | 60 |
| Geographic Diversification | 75 |
| Factor | Score |
|---|---|
| Valuation | 75 |
| Profitability | 78 |
| Growth | 70 |
| Balance Sheet Health | 75 |
| Cash Flow | 85 |
| Dividends | 90 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 50 |
| Volume Confirmation | 70 |
| Support & Resistance | 65 |
| Short-Term Oscillators | 40 |
Strong Cash Position and Low Debt
The company maintains a substantial cash and cash equivalents balance of $20.07 billion (as of Q4 2024) alongside a manageable debt level of $18.72 billion. This strong liquidity provides financial flexibility and resilience.
Attractive Price-to-Earnings Ratio
The trailing P/E ratio of 12.71 is competitive, especially considering the company's business in the financial services sector, suggesting potential undervaluation relative to earnings.
Recent Negative Momentum
The stock has experienced negative performance over the last month (-2.71%), 6 months (-9.31%), and year-to-date (-3.56%), indicating recent selling pressure and potential for further downside.
EPS Misses and Volatility
The company has missed earnings estimates in several recent quarters (e.g., Q4 2024 estimate 2.17, reported 1.95; Q2 2023 estimate 1.83, reported 1.52), suggesting potential forecasting challenges or operational headwinds.
August 2025
5
Ex-Dividend Date
August 2025
7
Next Earnings Date
H: $2.45
A: $2.16
L: $2.02
H: 19.28B
A: 18.46B
L: 17.83B
September 2025
9
Next Dividend Date
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.
94.14 USD
The 39 analysts offering 1 year price forecasts for MET have a max estimate of 110.00 and a min estimate of 73.00.